A detailed history of Alaska Permanent Fund Corp transactions in United Therapeutics Corp stock. As of the latest transaction made, Alaska Permanent Fund Corp holds 11,924 shares of UTHR stock, worth $4.3 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
11,924
Previous 11,924 -0.0%
Holding current value
$4.3 Million
Previous $3.8 Million 12.48%
% of portfolio
0.06%
Previous 0.06%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$228.26 - $319.04 $856,431 - $1.2 Million
3,752 Added 45.91%
11,924 $3.8 Million
Q1 2024

Apr 09, 2024

BUY
$210.76 - $249.51 $1.25 Million - $1.48 Million
5,921 Added 263.04%
8,172 $1.88 Million
Q4 2023

Feb 01, 2024

SELL
$214.88 - $256.94 $231,855 - $277,238
-1,079 Reduced 32.4%
2,251 $494,000
Q3 2023

Oct 31, 2023

BUY
$211.82 - $248.24 $12,073 - $14,149
57 Added 1.74%
3,330 $752,000
Q2 2023

Jul 31, 2023

BUY
$205.19 - $232.99 $612,286 - $695,242
2,984 Added 1032.53%
3,273 $722,000
Q4 2022

Feb 08, 2023

BUY
$205.95 - $280.43 $11,739 - $15,984
57 Added 24.57%
289 $80,000
Q3 2022

Oct 31, 2022

SELL
$203.3 - $244.17 $1,016 - $1,220
-5 Reduced 2.11%
232 $49,000
Q2 2022

Aug 09, 2022

SELL
$174.81 - $241.14 $2.52 Million - $3.48 Million
-14,443 Reduced 98.39%
237 $56,000
Q1 2022

Apr 26, 2022

SELL
$166.16 - $213.96 $7,643 - $9,842
-46 Reduced 0.31%
14,680 $2.63 Million
Q4 2021

Feb 14, 2022

BUY
$184.32 - $216.08 $41,656 - $48,834
226 Added 1.56%
14,726 $2.97 Million
Q2 2021

Aug 10, 2021

SELL
$170.47 - $211.93 $1.19 Million - $1.48 Million
-7,000 Reduced 32.56%
14,500 $2.6 Million
Q3 2020

Oct 29, 2020

BUY
$99.9 - $121.13 $1 Million - $1.22 Million
10,060 Added 87.94%
21,500 $2.17 Million
Q1 2020

May 05, 2020

BUY
$79.39 - $115.35 $908,221 - $1.32 Million
11,440 New
11,440 $1.09 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.4B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Alaska Permanent Fund Corp Portfolio

Follow Alaska Permanent Fund Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alaska Permanent Fund Corp, based on Form 13F filings with the SEC.

News

Stay updated on Alaska Permanent Fund Corp with notifications on news.